{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:29:23Z","timestamp":1785536963492,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/jgp.0b013e318227f4da","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T07:39:26Z","timestamp":1311147566000},"page":"505-513","source":"Crossref","is-referenced-by-count":80,"title":["Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial"],"prefix":"10.1016","volume":"20","author":[{"given":"Cynthia","family":"Fields","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Drye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Lyketsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","article-title":"Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic\u2013pituitary\u2013adrenal axis in severe depression","volume":"49","author":"Maes","year":"1993","journal-title":"Psychiatry Res"},{"issue":"11","key":"10.1097\/JGP.0b013e318227f4da_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"issue":"1\/2","key":"10.1097\/JGP.0b013e318227f4da_bib4","first-page":"11","article-title":"Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression","volume":"20","author":"van West","year":"1999","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"10.1097\/JGP.0b013e318227f4da_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archpsyc.1983.01790040059008","article-title":"CSF prostaglandin levels in depressed and schizophrenic patients","volume":"40","author":"Linnoila","year":"1983","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0262-1746(83)90048-3","article-title":"Elevated levels of prostaglandin E2 and thromboxane B2 in depression","volume":"10","author":"Lieb","year":"1983","journal-title":"Prostaglandins Leukot Med"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-1781(86)90040-5","article-title":"Depression, immunocompetence, and prostaglandins of the E series","volume":"17","author":"Calabrese","year":"1986","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-3223(88)90283-1","article-title":"Increased level of salivary prostaglandins in patients with major depression","volume":"23","author":"Ohishi","year":"1988","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1176\/ajp.146.3.365","article-title":"Salivary prostaglandin concentrations: possible state indicators for major depression","volume":"146","author":"Nishino","year":"1989","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/brbi.2000.0597","article-title":"The relationship of depression and stressors to immunological assays: a meta-analytic review","volume":"15","author":"Zorrilla","year":"2001","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11920-008-0042-1","article-title":"Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications","volume":"10","author":"Bruce","year":"2008","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ncl.2006.03.007","article-title":"Depression and immunity: inflammation and depressive symptoms in multiple sclerosis","volume":"24","author":"Gold","year":"2006","journal-title":"Neurol Clin"},{"issue":"13","key":"10.1097\/JGP.0b013e318227f4da_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1097\/JGP.0b013e318227f4da_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1\/2","key":"10.1097\/JGP.0b013e318227f4da_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","article-title":"Endotoxin produces a depressive-like episode in rats","volume":"711","author":"Yirmiya","year":"1996","journal-title":"Brain Res"},{"issue":"5","key":"10.1097\/JGP.0b013e318227f4da_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0893-133X(00)00226-8","article-title":"Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents","volume":"24","author":"Yirmiya","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1097\/JGP.0b013e318227f4da_bib18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1749-6632.1998.tb09597.x","article-title":"Cytokines and sickness behavior","volume":"840","author":"Dantzer","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-8993(96)01295-4","article-title":"Intracerebral administration of mycoplasma fermentans produces sickness behavior: role of prostaglandins","volume":"749","author":"Yirmiya","year":"1997","journal-title":"Brain Res"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/gerona\/58.3.M249","article-title":"Depression in late life: review and commentary","volume":"58","author":"Blazer","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9475","key":"10.1097\/JGP.0b013e318227f4da_bib21","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(05)66665-2","article-title":"Depression in the elderly","volume":"365","author":"Alexopoulos","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1097\/JGP.0b013e318227f4da_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1023\/A:1025388203548","article-title":"Biological risk factors for late life depression","volume":"18","author":"Tiemeier","year":"2003","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jad.2007.07.002","article-title":"Inflammatory markers in late-life depression: results from a population-based study","volume":"106","author":"Bremmer","year":"2008","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00001648-200301000-00025","article-title":"Inflammatory proteins and depression in the elderly","volume":"14","author":"Tiemeier","year":"2003","journal-title":"Epidemiology"},{"issue":"5","key":"10.1097\/JGP.0b013e318227f4da_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0006-3223(02)01811-5","article-title":"Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study","volume":"54","author":"Penninx","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psychres.2007.07.019","article-title":"Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression","volume":"161","author":"Dimopoulos","year":"2008","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.ajp.162.1.175","article-title":"Increase in interleukin-1beta in late-life depression","volume":"162","author":"Thomas","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1097\/JGP.0b013e318227f4da_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.exger.2007.01.011","article-title":"Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age","volume":"42","author":"van den Biggelaar","year":"2007","journal-title":"Exp Gerontol"},{"issue":"11","key":"10.1097\/JGP.0b013e318227f4da_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.biopsych.2008.11.011","article-title":"Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study","volume":"65","author":"Milaneschi","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1097\/JGP.0b013e318227f4da_bib31","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/sj.npp.1301649","article-title":"Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system","volume":"33","author":"Godbout","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1\/2","key":"10.1097\/JGP.0b013e318227f4da_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(98)00217-3","article-title":"Increased interleukin-6 expression by microglia from brain of aged mice","volume":"93","author":"Ye","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000049025","article-title":"An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice","volume":"9","author":"Ye","year":"2001","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib34","first-page":"247","article-title":"Anti-inflammatory and side effects of cyclooxygenase inhibitors","volume":"59","author":"Suleyman","year":"2007","journal-title":"Pharmacol Rep"},{"issue":"suppl 5","key":"10.1097\/JGP.0b013e318227f4da_bib35","first-page":"113","article-title":"Inhibitors of cyclooxygenases: mechanisms, selectivity and uses","volume":"57","author":"Botting","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1097\/JGP.0b013e318227f4da_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1097\/JGP.0b013e318227f4da_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jnr.10192","article-title":"Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat","volume":"68","author":"Casolini","year":"2002","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1097\/JGP.0b013e318227f4da_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000107420","article-title":"Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression","volume":"14","author":"Myint","year":"2007","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20133","key":"10.1097\/JGP.0b013e318227f4da_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.03.076","article-title":"Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain","volume":"612","author":"Guo","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1097\/JGP.0b013e318227f4da_bib40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"Muller","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1097\/JGP.0b013e318227f4da_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depress Anxiety"},{"issue":"2","key":"10.1097\/JGP.0b013e318227f4da_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum Psychopharmacol"},{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00004850-200607000-00004","article-title":"Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression","volume":"21","author":"Brunello","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200607000-00005","article-title":"Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study","volume":"21","author":"Mendlewicz","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"10.1097\/JGP.0b013e318227f4da_bib45","first-page":"709","article-title":"Geriatric Depression Scale","volume":"24","author":"Yesavage","year":"1988","journal-title":"Psychopharmacol Bull"},{"issue":"7","key":"10.1097\/JGP.0b013e318227f4da_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archneur.2008.65.7.nct70006","article-title":"Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib","volume":"65","author":"ADAPT Research Group","year":"2008","journal-title":"Arch Neurol"},{"issue":"21","key":"10.1097\/JGP.0b013e318227f4da_bib47","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"ADAPT Research Group Lyketsos","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1097\/JGP.0b013e318227f4da_bib48","first-page":"314","article-title":"The Modified Mini-Mental State (3MS) examination","volume":"48","author":"Teng","year":"1987","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1097\/JGP.0b013e318227f4da_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1983","journal-title":"J Psychiatr Res 1982\u2013"},{"issue":"6","key":"10.1097\/JGP.0b013e318227f4da_bib50","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/gps.2154","article-title":"Is the Geriatric Depression Scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment?","volume":"24","author":"Debruyne","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"10.1097\/JGP.0b013e318227f4da_bib51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-0447.2006.00888.x","article-title":"The criterion validity of the Geriatric Depression Scale: a systematic review","volume":"114","author":"Wancata","year":"2006","journal-title":"Acta Psychiatr Scand"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112620648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112620648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T08:23:19Z","timestamp":1543652599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748112620648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1064748112620648"],"URL":"https:\/\/doi.org\/10.1097\/jgp.0b013e318227f4da","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}